20135 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Delayed release cysteamine bead formulation, and methods of making and using same
#602Administration of oral methyldopa
#603Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates
#604Pulsatile drug delivery system for treating morning akinesia
#605Treatment of Constipation-Predominant Irritable Bowel Syndrome
#606Compositions and methods for reducing overdose
#607Drug and layered silicate composite with improved oral bioavailability, oral pharmacological composition containing the composite and method for producing the composite
#608Pharmaceutical composition and administrations thereof
#609Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides
#610Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases
#611Nutritional supplement for mammals
#612PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF
#613Tamper-resistant pharmaceutical compositions of opioids and other drugs
#614Compositions and Methods for Treating an Infection
#615Process of making stable abuse-deterrent oral formulations
#616Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#617Chemical-physical system for treating tinnitus
#618FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL
#619Esomeprazole-containing complex capsule and preparation method therefor
#620Monomethylfumarate Prodrug Compositions
#621ACID RESISTANT CAPSULES
#622Controlled-release solid dosage forms of mesalamine
#623PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
#624Enclosing materials in natural transport systems
#625Method and apparatus for the manufacture of softgels
#626PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
#627Dosage forms with desired release profiles and methods of designing and making thereof
#628Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
#629CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#630PREFABRICATED PHARMACEUTICAL DOSAGE FORMS FROM FUNCTIONAL POLYMER FILMS
#6315-aminosalicylic acid capsule formulation
#632Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#633FORMULATIONS
#634FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#635THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#636Drug delivery device having controlled delivery and confirmation
#637Swallowable drug delivery device and methods of drug delivery
#638ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS
#639Methods for treating helicobacter pylori infection
#640PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE
#641Swallowable drug delivery device and methods of drug delivery
#642TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#643Tamper resistant pharmaceutical formulations
#644Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#645Methods for treating cancer
#646Reloadable microcapsules
#647DELAYED-RELEASE TABLETS OF METHYLPHENIDATE
#648ABUSE-PROOFED ORAL DOSAGE FORM
#649Methods of treating multiple sclerosis
#650Compositions for treatment of attention deficit hyperactivity disorder
#651Once Daily Formulations Of Tetracyclines
#652Fast-acting plant-based medicinal compounds and nutritional supplements
#653Method of treatment using nanoparticulate ganaxolone formulations
#654GANAXOLONE FORMULATION AND USE THEREOF
#655Controlled release pharmaceutical compositions comprising a fumaric acid ester
#656Solid oral formulation of fenretinide
#657Pharmaceutical formulation containing gelling agent
#658METHOD AND APPARATUS FOR THE MANUFACTURE OF SOFTGELS
#659TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#660PREVENTION OF LIPID ABSORPTION USING ARTIFICIAL LIPID SEQUESTRATION DEVICES
#661Pharmaceutical Formulation Containing Gelling Agent
#662SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS
#663PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
#664Oral pharmaceutical compositions of mesalazine
#665FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#666Dietary nutrient compositions
#667CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#668CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#669CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#670Orally available articles containing at least one stabilized supplement therein
#671Milrinone controlled-release formulation
#672Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#673Drug delivery device
#674Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2
#675Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material
#676Galenic formulations of organic compounds
#677PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE
#678Timed, pulsatile release systems
#679Simmondsin formulation
#680FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#681Dimethyl fumarate particles and pharmaceutical compositions thereof
#682Pharmaceutical formulation containing gelling agent
#683Swallowable drug delivery device and method of delivery
#684Granular Pharmaceutical Composition
#685Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
#686Stabilized formulations of CNS compounds
#687TIZANIDINE FORMULATIONS
#688Enterically coated cysteamine, cystamine and derivatives thereof
#689TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#690Solid Dosage Forms
#691PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
#692Sprinkle formulations of acamprosate
#693Chemosensory receptor ligand-based therapies
#694Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
#695CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES
#696Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
#697Sumatriptan promethazine pharmaceutical compositions
#698METHOD AND APPARATUS FOR FORMING DELIVERY DEVICES FOR ORAL INTAKE OF AN AGENT
#699Treatment of Constipation-Predominant Irritable Bowel Syndrome
#700CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#701Ingestible medical delivery devices
#702SYSTEMS AND METHODS FOR DESIGNING AND MANUFACTURING MULTI-COMPARTMENT CAPSULES
#703Implantable drug delivery device
#704Fumarate ester pharmaceutical compositions
#705Fumarate ester dosage forms
#706Fumarate esters
#707SELF-EMULSIFYING DRUG DELIVERY SYSTEM
#708Pharmaceutical Formulation Containing Gelling Agent
#709Formulations and Dosage Forms of Oxidized Phospholipids
#710ABUSE-PROOFED DOSAGE FORM
#711Fumarate ester pharmaceutical compositions
#712Methods of Treating Multiple Sclerosis
#713POWDER COMPONENT-CONTAINING SEAMLESS CAPSULE AND METHOD FOR MANUFACTURING SAME
#714Dual release dosage form capsule and methods, devices and systems for making same
#715Biomedically active and delivery site specific capsule-in-capsule liver supplement apparatus and method of use thereof
#716GEMCABENE COMPOSITIONS AND METHODS OF USE THEREOF
#717Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#718Therapeutic delivery device
#719ENTERIC CAPSULE
#720Particulate delivery systems
#721Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#722TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#723CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#724PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
#725ACID-RESISTANT CAPSULE
#726FORMULATIONS COMPRISING CYCLOSPORIN A
#727Delayed sustained release pharmaceutical compositions
#728Beta-lactamase formulations and uses thereof
#729Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device
#730COAXIAL NOZZLE CONFIGURATION AND METHODS THEREOF
#731PHARMACEUTICAL COMPOSITIONS
#732CONTROLLED DOSE DRUG DELIVERY SYSTEM
#733Treating pain in patients with hepatic impairment
#734Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
#735Pharmaceutical formulations compromising nitrocatechol derivatives and methods of making thereof
#736Raloxifene sprinkle composition
#737PHARMACEUTICAL COMPOSITIONS
#738Use of NK-1 receptor antagonists in pruritus
#739CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#740Millicapsule formulations comprising polyunsaturated free fatty acids
#741Uses of milrinone controlled-release formulation
#742GEMCABENE COMBINATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#743PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
#744METHOD FOR A SLOW RELEASE OF DRUGS FROM ORALLY DISSOLVING CAPSULES
#745TAMPERPROOF DOSAGE FORM
#746Drug Delivery with Orally Dissolving Capsules
#747Pharmaceutical composition containing clomipramine and preparation method therefor
#748Authentication of medication delivery vehicle to facilitate medication release
#749SALTS AND COMPOSITIONS USEFUL FOR TREATING DISEASE
#750Implantable medical devices for extended release of therapeutic agents
#751Tamperproof oral dosage form
#752Composition for the prevention and/or treatment of allergy symptoms
#753USE OF NADPH FOR PREPARATION OF A DRUG FOR ANTIPLATELET AGGREGATION
#754METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA
#755NOVEL FORMULATION OF DICLOFENAC
#756Capsule with internal diaphragm and solid ingredients
#757FOOD INDEPENDENT IMMEDIATE RELEASE DRUG FORMULATION WITH ABUSE DETERRENCE AND OVERDOSE PROTECTION
#758Anti-methanogenic compositions and uses thereof
#759Process of making stable abuse-deterrent oral formulations
#760Capsule with volume-adjustable internal diaphragm
#761THERAPEUTIC DRUG COMPOSITIONS AND IMPLANTS FOR DELIVERY OF SAME
#762Method and apparatus for manufacturing a capsule
#763CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#764PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#765COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
#766Hard Capsule Shell Compositions for the Treatment of Irritable Bowel Syndrome
#767Compositions and methods for treating centrally mediated nausea and vomiting
#768Microbiota restoration therapy (MRT) compositions and methods of manufacture
#769METHOD FOR TREATING INTESTINAL FIBROSIS
#770ABUSE-PROOFED ORAL DOSAGE FORM
#771INHALABLE POWDER FORMULATIONS OF ALGINATE OLIGOMERS
#772Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#773Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#774Enteric capsule
#775Therapeutic composition comprising insulin prepared for delivery into an intestinal tract
#776Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
#777PHOTO-RESPONSIVE MACRO- AND MICRO- LIQUID MARBLES
#778Oral pharmaceutical dosage forms
#779PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN
#780Pharmaceutical Composition Containing Celecoxib and Tramadol
#781USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE
#782Formulations of n-acetylcysteine and uses thereof
#783FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL
#784MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#785PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#786Device and method to treat esophageal disorders
#787Cell lines and their use in encapsulated cell biodelivery
#788Composite preparation of mosapride and rabeprazole
#789Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#790EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF MIXED AMPHETAMINES
#791Drug delivery capsule
#792CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
#793Treatment of Constipation-Predominant Irritable Bowel Syndrome
#794Pharmaceutical Formulation Containing Gelling Agent
#795Nicotinamide compositions and the therapeutic use thereof
#796Treatment of NASH with Gemcabene
#797Abiraterone acetate lipid formulations
#798Pharmaceutical Formulation Containing Gelling Agent
#799Multi-shell Capsule
#800Stimulant abuse-deterrent compositions
#801ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#802Hydroxycitric acid compounds and capsule liquid delivery
#803Methods for manufacturing capsules with ingestible event markers
#804Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#805Process for producing layered bodies
#806PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#807ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#808CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#809Raloxifene sprinkle composition
#810ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#811Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#812Layered bodies and compositions containing them
#813Controlled release pharmaceutical formulations of nitozoxanide
#814Extended relief dosage form
#815ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
#816Microbiota restoration therapy (MRT) compositions and methods of manufacture
#817TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#818Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them
#819GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#820PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
#821Fumarate ester pharmaceutical compositions
#822Pharmaceutical formulation containing gelling agent
#823Medical devices and implements with liquid-impregnated surfaces
#824Controlled release oral pharmaceutical dosage forms comprising MGBG
#825Tamper resistant oral opioid agonist formulations
#826Pharmaceutical dosage form for application to mucous membranes
#827Abuse-deterrent pharmaceutical compositions of opioids and other drugs
#828CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#829PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
#830GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN-PARTICLECONTAINING CELLS, METHOD FOR PRODUCING GELATIN-PARTICLE-CONTAINING CELLS, AND CELLULAR STRUCTURE
#831Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#832Neuroprotection in Demyelinating Diseases
#833STABILIZED DIALKYL FUMARATE COMPOSITIONS
#834Pharmaceutical formulation containing gelling agent
#835Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#836COMPOSITIONS AND METHODS FOR TREATMENT IN PARKINSON'S DISEASE PATIENTS
#837Enteric soft capsule compositions
#838Multi-compartment capsule
#839Device, system and methods for the oral delivery of therapeutic compounds
#840EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
#841CONTROLLED RELEASE PREPARATIONS
#842Stable Compositions comprising Linaclotide
#843Methods of Treating Multiple Sclerosis
#844Pharmaceutical composition of aprepitant
#845Pharmaceutical compositions for colon-specific delivery
#846PHARMACEUTICAL COMPOSITION COMPRISING TOPIRAMATE
#847Process of making stable abuse-deterrent oral formulations
#848COMPOSITE CAPSULES COMPRISING RALOXIFENE, AND VITAMIN D OR ITS DERIVATIVES
#849Methods of treating multiple sclerosis
#850PHARMACEUTICAL COMPOSITIONS
#851Separable capsule
#852Abuse-deterrent drug formulations
#853Methods of Treating Multiple Sclerosis
#854PHARMACEUTICAL COMPOSITIONS
#855PHARMACEUTICAL COMPOSITIONS
#856Pharmaceutical compositions
#857Method of treating heart failure with preserved ejection fraction by administering milrinone
#858Use of NK-1 receptor antagonists in pruritus
#859SENSORS FOR ORAL DOSAGE FORMS
#860CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
#861Raloxifene sprinkle composition
#862Formulations of histone deacetylase inhibitor and uses thereof
#863Salts and compositions useful for treating disease
#864Separable capsule for sprinkling applications
#865Device and method for reducing calorie intake
#866Method and apparatus for the manufacture of softgels
#867Abrasion-Resistant Opioid Formulations
#868Tamper-resistant pharmaceutical compositions of opioids and other drugs
#869Enterically coated cysteamine, cystamine and derivatives thereof
#870Enterically coated cysteamine, cystamine and derivatives thereof
#871Enterically coated cysteamine, cystamine and derivatives thereof
#872DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#873DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#874DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#875CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#876Method and composition for treating Alzheimer-type dementia
#877Low Dose Pharmaceutical Composition
#878Dosage form articles for external mucosal applications
#879Dosage form articles for delayed release
#880PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
#881PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS
#882COMPOSITIONS FOR CONTROL OF DRUG ABUSE
#883MODIFIED RELEASE ABUSE DETERRENT DOSAGE FORMS
#884Treatment of Constipation-Predominant Irritable Bowel Syndrome
#885Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
#886Pharmaceutical formulation of palbociclib and a preparation method thereof
#887Oral pharmaceutical dosage forms of budesonide
#888SYSTEM FOR UPPER INTESTINAL DELIVERY OF ACTIVE INGREDIENTS
#889Miniature ingestible device
#890ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS
#891Compositions and methods for reducing overdose
#892Pharmaceutical Compositions for Colon-Specific Delivery
#893Composition for the prevention and/or treatment of allergy symptoms
#894Oral pharmaceutical dosage forms
#895Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
#896Capsule dispensing container
#897Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#898Ingestible device with pharmaceutical product
#899Tamper resistant pharmaceutical formulations
#900CAPSULE FORMULATION